Cyfuse Biomedical K.K. (TYO:4892)
Japan · Delayed Price · Currency is JPY 651.00
-25.00 (-3.70%)
Jan 21, 2026, 3:30 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 5.41 billion as of January 21, 2026. Its market cap has increased by 47.07% in one year.
Market Cap
5.41B
Enterprise Value
2.91B
Revenue
89.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
651.00
Market Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 5.41B, a decrease of -58.42%. That is a compound annual growth rate of -24.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 5.41B | 10.34% |
| Dec 30, 2025 | 4.90B | 33.26% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
| Dec 1, 2022 | 13.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 20.03B |
| Pharma Foods International | 19.86B |
| Taiko Pharmaceutical | 14.97B |
| Wakamoto Pharmaceutical | 11.03B |
| Morishita Jintan | 9.23B |
| Solasia Pharma K.K. | 7.82B |
| MedRx | 7.24B |
| WDB coco | 6.64B |